Global and China Genome Editing Dynamic Monitoring and Future Investment Report 2023

Report ID: ARS1460 | Category: Healthcare | Pages: 99 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$4350.00 Multi User-$7500.00

Report Description
View Table of Contents

Report Summary

The report aims at estimating the market size and future growth potential of Genome Editing market across different segments such as type, application and geography. The base year considered for the study is 2022, and the market size is forecast from 2023 to 2029.

The global Genome Editing market size in 2022 is XX million US dollars, and it is expected to be 17910.0 million US dollars by 2029, with a compound annual growth rate of 17.00% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Genome Editing market include Merck KGaA (Germany), GenScript (China), Sangamo Therapeutics (U.S.), Lonza (Switzerland), and Editas Medicine (U.S.). The share of the top 3 players in the Genome Editing market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Genome Editing market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. CRISPR accounted for XX% of Genome Editing market in 2022. TALEN share of XX%.
Cell Line Engineering accounted for XX% of the Genome Editing market in 2022. Genetic Engineering accounts for XX%.

The research methodology used to estimate and forecast the Genome Editing market begins by capturing data on key market player revenues through secondary research. The bottom-up procedure has been employed to arrive at the overall market size, by considering the revenue of key players in the market. After arriving at the overall market size, the total market has been split into several segments and sub-segments, which has been verified through primary research by conducting extensive interviews with key people such as industry experts, executives. This data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for segments and sub-segments.

This report provides the integrated ecosystem of the Genome Editing market which offers holistic view of current demand and vendor side market. The research study answers several significant questions, primarily which market segments to focus on in next two to five years to prioritize factors such as resource effort, and investment.

Key Target audience:
Genome Editing Manufacturers and Suppliers
Research and Development (R&D) Companies
Business Research and Consulting Service Providers
Research Organizations
Academic Centers and Universities Associations and Industrial Bodies
Technology Investors

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Highlights-Regions

North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico

Player list
Merck KGaA (Germany)
GenScript (China)
Sangamo Therapeutics (U.S.)
Lonza (Switzerland)
Editas Medicine (U.S.)
CRISPR Therapeutics (Switzerland)
Tecan Trading AG (Switzerland)
Precision Biosciences (U.S.)
PerkinElmer Inc. (U.S.)
Cellectis S.A (France)
Genome Medical, Inc. (U.S.)
BioMed Central Ltd (U.K.)
Aevi Genomic Medicine, Inc. (Israel)
Congenica Ltd. (U.K.)
Deep Genomics (Canada)
Editas Medicine (U.S.)
Illumina, Inc. (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
QIAGEN N.V. (Netherlands)
Agilent Technologies, Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)

Types list
CRISPR
TALEN
ZFN
ANTISENSE
Other Technologies

Application list
Cell Line Engineering
Genetic Engineering
Diagnostic Applications
Drug Discovery and Development
Other Applications

Table of Content

1 Genome Editing  Market Introduction and Overview
1.1 Genome Editing  Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
2 Genome Editing  Business Cost Analysis
2.1 Proportion of Manufacturing Cost Structure
2.1.1 Labor Cost
2.1.2 Operating Expenses
2.2 Genome Editing  Industrial Chain Analysis
3 Market Competition by Manufacturers
3.1 Global Genome Editing  Revenue and Market Share by Manufacturer
3.2 Manufacturers Genome Editing  Production Sites, Area Served, Product Types
3.3 Genome Editing  Market Competitive Situation and Trends
3.3.1 Genome Editing  Market Concentration Rate
3.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
3.3.3 Mergers & Acquisitions, Expansion
4 Players Profiles
4.1  Merck KGaA (Germany)
4.1.1 Merck KGaA (Germany) Company Profile
4.1.2 Genome Editing  Product Overview
4.1.3 Merck KGaA (Germany) Genome Editing  Market Performance (2018-2023)
4.1.4 Merck KGaA (Germany) Business Overview
4.2  GenScript (China)
4.2.1 GenScript (China) Company Profile
4.2.2 Genome Editing  Product Overview
4.2.3 GenScript (China) Genome Editing  Market Performance (2018-2023)
4.2.4 GenScript (China) Business Overview
4.3  Sangamo Therapeutics (U.S.)
4.3.1 Sangamo Therapeutics (U.S.) Company Profile
4.3.2 Genome Editing  Product Overview
4.3.3 Sangamo Therapeutics (U.S.) Genome Editing  Market Performance (2018-2023)
4.3.4 Sangamo Therapeutics (U.S.) Business Overview
4.4  Lonza (Switzerland)
4.4.1 Lonza (Switzerland) Company Profile
4.4.2 Genome Editing  Product Overview
4.4.3 Lonza (Switzerland) Genome Editing  Market Performance (2018-2023)
4.4.4 Lonza (Switzerland) Business Overview
4.5  Editas Medicine (U.S.)
4.5.1 Editas Medicine (U.S.) Company Profile
4.5.2 Genome Editing  Product Overview
4.5.3 Editas Medicine (U.S.) Genome Editing  Market Performance (2018-2023)
4.5.4 Editas Medicine (U.S.) Business Overview
4.6  CRISPR Therapeutics (Switzerland)
4.6.1 CRISPR Therapeutics (Switzerland) Company Profile
4.6.2 Genome Editing  Product Overview
4.6.3 CRISPR Therapeutics (Switzerland) Genome Editing  Market Performance (2018-2023)
4.6.4 CRISPR Therapeutics (Switzerland) Business Overview
4.7  Tecan Trading AG (Switzerland)
4.7.1 Tecan Trading AG (Switzerland) Company Profile
4.7.2 Genome Editing  Product Overview
4.7.3 Tecan Trading AG (Switzerland) Genome Editing  Market Performance (2018-2023)
4.7.4 Tecan Trading AG (Switzerland) Business Overview
4.8  Precision Biosciences (U.S.)
4.8.1 Precision Biosciences (U.S.) Company Profile
4.8.2 Genome Editing  Product Overview
4.8.3 Precision Biosciences (U.S.) Genome Editing  Market Performance (2018-2023)
4.8.4 Precision Biosciences (U.S.) Business Overview
4.9  PerkinElmer Inc. (U.S.)
4.9.1 PerkinElmer Inc. (U.S.) Company Profile
4.9.2 Genome Editing  Product Overview
4.9.3 PerkinElmer Inc. (U.S.) Genome Editing  Market Performance (2018-2023)
4.9.4 PerkinElmer Inc. (U.S.) Business Overview
4.10  Cellectis S.A (France)
4.10.1 Cellectis S.A (France) Company Profile
4.10.2 Genome Editing  Product Overview
4.10.3 Cellectis S.A (France) Genome Editing  Market Performance (2018-2023)
4.10.4 Cellectis S.A (France) Business Overview
4.11  Genome Medical, Inc. (U.S.)
4.11.1 Genome Medical, Inc. (U.S.) Company Profile
4.11.2 Genome Editing  Product Overview
4.11.3 Genome Medical, Inc. (U.S.) Genome Editing  Market Performance (2018-2023)
4.11.4 Genome Medical, Inc. (U.S.) Business Overview
4.12  BioMed Central Ltd (U.K.)
4.12.1 BioMed Central Ltd (U.K.) Company Profile
4.12.2 Genome Editing  Product Overview
4.12.3 BioMed Central Ltd (U.K.) Genome Editing  Market Performance (2018-2023)
4.12.4 BioMed Central Ltd (U.K.) Business Overview
4.13  Aevi Genomic Medicine, Inc. (Israel)
4.13.1 Aevi Genomic Medicine, Inc. (Israel) Company Profile
4.13.2 Genome Editing  Product Overview
4.13.3 Aevi Genomic Medicine, Inc. (Israel) Genome Editing  Market Performance (2018-2023)
4.13.4 Aevi Genomic Medicine, Inc. (Israel) Business Overview
4.14  Congenica Ltd. (U.K.)
4.14.1 Congenica Ltd. (U.K.) Company Profile
4.14.2 Genome Editing  Product Overview
4.14.3 Congenica Ltd. (U.K.) Genome Editing  Market Performance (2018-2023)
4.14.4 Congenica Ltd. (U.K.) Business Overview
4.15  Deep Genomics (Canada)
4.15.1 Deep Genomics (Canada) Company Profile
4.15.2 Genome Editing  Product Overview
4.15.3 Deep Genomics (Canada) Genome Editing  Market Performance (2018-2023)
4.15.4 Deep Genomics (Canada) Business Overview
4.16  Editas Medicine (U.S.)
4.16.1 Editas Medicine (U.S.) Company Profile
4.16.2 Genome Editing  Product Overview
4.16.3 Editas Medicine (U.S.) Genome Editing  Market Performance (2018-2023)
4.16.4 Editas Medicine (U.S.) Business Overview
4.17  Illumina, Inc. (U.S.)
4.17.1 Illumina, Inc. (U.S.) Company Profile
4.17.2 Genome Editing  Product Overview
4.17.3 Illumina, Inc. (U.S.) Genome Editing  Market Performance (2018-2023)
4.17.4 Illumina, Inc. (U.S.) Business Overview
4.18  Thermo Fisher Scientific Inc. (U.S.)
4.18.1 Thermo Fisher Scientific Inc. (U.S.) Company Profile
4.18.2 Genome Editing  Product Overview
4.18.3 Thermo Fisher Scientific Inc. (U.S.) Genome Editing  Market Performance (2018-2023)
4.18.4 Thermo Fisher Scientific Inc. (U.S.) Business Overview
4.19  QIAGEN N.V. (Netherlands)
4.19.1 QIAGEN N.V. (Netherlands) Company Profile
4.19.2 Genome Editing  Product Overview
4.19.3 QIAGEN N.V. (Netherlands) Genome Editing  Market Performance (2018-2023)
4.19.4 QIAGEN N.V. (Netherlands) Business Overview
4.20  Agilent Technologies, Inc. (U.S.)
4.20.1 Agilent Technologies, Inc. (U.S.) Company Profile
4.20.2 Genome Editing  Product Overview
4.20.3 Agilent Technologies, Inc. (U.S.) Genome Editing  Market Performance (2018-2023)
4.20.4 Agilent Technologies, Inc. (U.S.) Business Overview
4.21  Bio-Rad Laboratories, Inc. (U.S.)
4.21.1 Bio-Rad Laboratories, Inc. (U.S.) Company Profile
4.21.2 Genome Editing  Product Overview
4.21.3 Bio-Rad Laboratories, Inc. (U.S.) Genome Editing  Market Performance (2018-2023)
4.21.4 Bio-Rad Laboratories, Inc. (U.S.) Business Overview
5 Global Genome Editing  Historical and Forecast Market Analysis by Type
5.1 Market Size Analysis by Types
5.2 Global Genome Editing  Revenue and Market Share by Type
5.3 Global Genome Editing  Revenue Market Forecast by Type (2023-2029)
6 Global Genome Editing  Historical and Forecast Market Analysis by Application
6.1 Market Size Analysis by Application
6.2 Global Genome Editing  Revenue Market Share by Application (2018-2023)
6.3 Genome Editing  Revenue Market Forecast by Application (2023-2029)
7 Global Market Growth Trends Analysis
7.1 Global Genome Editing  Market Size & Forecast (2018-2029)
7.2 Genome Editing  Growth Trends Analysis by Regions
7.2.1 Genome Editing  Market Size by Regions: 2018 VS 2023 VS 2029
7.2.2 Genome Editing  Historic Revenue Market Size by Regions (2018-2023)
7.2.3 Genome Editing  Forecasted Revenue Market Size by Regions (2023-2029)
7.2.4 North America Genome Editing  Market Size & Forecast (2018-2029)
7.2.5 EMEA Genome Editing  Market Size & Forecast (2018-2029)
7.2.6 China Genome Editing  Market Size & Forecast (2018-2029)
7.2.7 Asia-Pacific (Excluding China) Genome Editing  Market Size & Forecast (2018-2029)
7.2.8 Latin America Genome Editing  Market Size & Forecast (2018-2029)
8 North America
8.1 North America Genome Editing  Revenue by Players
8.2 North America Genome Editing  Revenue by Types
8.3 North America Genome Editing  Revenue by Applications
8.4 North America Genome Editing  Market by Countries
8.4.1 North America Genome Editing  Revenue by Countries (2018-2029)
8.5 North America SWOT Analysis
8.6 United States
8.7 Canada
9 China
9.1 China Genome Editing  Revenue by Players
9.2 China Genome Editing  Revenue by Types
9.3 China Genome Editing  Revenue by Applications
9.4 China SWOT Analysis
9.5 China
10 Asia Pacific (Excluding China)
10.1 Asia Pacific Genome Editing  Revenue by Players
10.2 Asia Pacific Genome Editing  Revenue by Types
10.3 Asia Pacific Genome Editing  Revenue by Applications
10.4 Asia Pacific Genome Editing  Market by Countries
10.4.1 Asia Pacific Genome Editing  Revenue by Countries (2018-2029)
10.5 Asia Pacific SWOT Analysis
10.6 Japan
10.7 Korea
10.8 Southeast Asia
10.9 India
10.10 Australia
11 EMEA
11.1 EMEA Genome Editing  Revenue by Players
11.2 EMEA Genome Editing  Revenue by Types
11.3 EMEA Genome Editing  Revenue by Applications
11.4 EMEA Genome Editing  Market by Countries
11.4.1 EMEA Genome Editing  Revenue by Countries (2018-2029)
11.5 EMEA SWOT Analysis
11.6 Europe
11.6.1 Europe Genome Editing  Revenue by Countries (2018-2029)
11.6.2 Germany
11.6.3 France
11.6.4 UK
11.6.5 Italy
11.6.6 Russia
11.6.7 Nordic
11.7 Middle East
11.8 Africa
12 Latin America
12.1 Latin America Genome Editing  Revenue by Players
12.2 Latin America Genome Editing  Revenue by Types
12.3 Latin America Genome Editing  Revenue by Applications
12.4 Latin America Genome Editing  Market by Countries
12.4.1 Latin America Genome Editing  Revenue by Countries (2018-2029)
12.5 Latin America SWOT Analysis
12.6 Brazil
12.7 Argentina
12.8 Mexico
13 Genome Editing  Industry Dynamic Analysis
13.1 Genome Editing  Market Trends Analysis
13.2 Genome Editing  Market Drivers Analysis
13.3 Genome Editing  Market Challenges Analysis
13.4 Genome Editing  Market Restraints Analysis
14 Research Findings and Conclusion

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global and China Genome Editing Dynamic Monitoring and Future Investment Report 2023

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?